Cochrane COVID-19 Study Register
AboutHelp
Back to Search Results
EUCTR2020-000982-18-NO

A clinical study to evaluate the efficacy of different anti-viral drugs in SARS-CoV-2 infected patients (COVID-19)

  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Unclear
  1. Population (7)
  2. Male and Female
  3. COVID-19
  4. Adult
  5. Aged (65+)
  1. Intervention (4)
  2. Usual Care
  3. Remdesivir
  4. Hydroxychloroquine
  1. Comparison (2)
  2. Hydroxychloroquine
  3. Remdesivir
  1. Outcome (6)
  2. Length Of Stay
  3. Infection
  4. Organ dysfunction
  5. SARS-CoV-2 Virus
  6. Death
  7. Mechanical ventilation

A clinical study to evaluate the efficacy of different anti-viral drugs in SARS-CoV-2 infected patients (COVID-19)

EUCTR2020-000982-18-NO
First Published 24/03/2020ICTRP (https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000982-18)
Trial registry record
No Results
Main objective: To investigate the effect of Remdesivir and Hydroxychloroquine on all-cause in-hospital mortality in moderate and in severe COVID 19. Inclusion criteria: 1. Adult patients, 18 years and above 2. Confirmed SARS-2-CoV-2 infection by PCR 3. Admitted to the hospital ward or the ICU 4. Subjects (or legally authorized representative) provides written informed consent prior to initiation of the study 5. No anticipated transfer within 72 hours to a non-study hospital